MedPath

HEMLIBRA 30 MG/ML SOLUCION INYECTABLE

HEMLIBRA 30 MG/ML SOLUCION INYECTABLE

Commercialized
Register Number

1181271001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Apr 9, 2018

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181271001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

EMICIZUMABActive
Quantity: 30 mg
Name: EMICIZUMAB

ATC CLASSIFICATION (3)

B02B
B02BX
B02BX06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.